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The innate immune system senses pathogen-
specifi  c molecular patterns via pattern recogni-
tion receptors, such as Toll-like receptors (TLRs; 
references 1–3). 12 TLR family members have 
been identifi  ed in mammals, and the pathogen-
specifi  c molecular patterns recognized by these 
TLRs have been mostly identifi  ed. The cyto-
plasmic portion of TLRs, called TIR (Toll/IL-1 
receptor [IL-1R]) domain, resembles that of 
IL-1R family members, and these two receptor 
families in part share intracellular signaling 
machineries. Stimulation with TLR ligands or 
IL-1 family cytokines recruits a TIR domain–
containing adaptor, MyD88, to the receptors. 
IL-1R–associated kinases (IRAKs) are recruited 
to MyD88 through a homophilic interaction 
of the death domains and associate with TNF 
receptor–associated factor 6 (TRAF6), which acts 
as an ubiquitin protein ligase. TRAF6 catalyzes 
the formation of a K63-linked polyubiquitin 
chain on TRAF6 itself and on IκB kinase γ 
(IKK-γ)/NF-κB essential modulator. TGF-β–
activated kinase 1 is also recruited to TRAF6 
and then phosphorylates IKK-β and mitogen-
activated protein (MAP) kinase kinase 6. Phos-
phorylation of IκB by the IKK complex leads to 
its degradation, and freed NF-κB translocates 
into the nucleus, resulting in induction of genes 
involved in infl  ammatory responses as well as 
increase in the surface expression of costimula-
tory molecules on innate immune cells. The ac-
tivation of MAP kinase cascade is responsible 
for AP-1–induced gene expression. In addition 
to the MyD88-dependent signaling pathway, 
the TLR4 signaling also activates a MyD88-
independent signaling cascade via another TIR 
domain–containing adaptor protein inducing 
IFN-β, TRIF (4). It triggers the signaling cas-
cade leading to the production of type I IFNs 
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Interleukin-1 receptor–associated kinase 4 (IRAK-4) was reported to be essential for the 
Toll-like receptor (TLR)– and T cell receptor (TCR)–mediated signaling leading to the 
activation of nuclear factor 𝗋B (NF-𝗋B). However, the importance of kinase activity of 
IRAK family members is unclear. In this study, we investigated the functional role of IRAK-4 
activity in vivo by generating mice carrying a knockin mutation (KK213AA) that abro-
gates its kinase activity. IRAK-4KN/KN mice were highly resistant to TLR-induced shock 
response. The cytokine production in response to TLR ligands was severely impaired in 
IRAK-4KN/KN as well as IRAK-4−/− macrophages. The IRAK-4 activity was essential for the 
activation of signaling pathways leading to mitogen-activated protein kinases. TLR-
induced IRAK-4/IRAK-1–dependent and –independent pathways were involved in early 
induction of NF-𝗋B–regulated genes in response to TLR ligands such as tumor necrosis 
factor 𝗂 and I𝗋B𝗇. In contrast to a previous paper (Suzuki, N., S. Suzuki, D.G. Millar, 
M. Unno, H. Hara, T. Calzascia, S. Yamasaki, T. Yokosuka, N.J. Chen, A.R. Elford, et al. 
2006. Science. 311:1927–1932), the TCR signaling was not impaired in IRAK-4−/− and 
IRAK-4KN/KN mice. Thus, the kinase activity of IRAK-4 is essential for the regulation of 
TLR-mediated innate immune responses.
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via IKK-related kinases, TANK-binding kinase 1 (TBK1) and 
IKK-i.  The TLR3 signaling also entirely relies on TRIF to 
activate NF-κB and IFN-regulatory factors.
The IRAK family is comprised of four members and is 
characterized by the presence of an N-terminal death domain 
and a serine/threonine kinase domain (5). IRAK-1 was ini-
tially identifi  ed as a kinase that is coprecipitated with IL-1R 
in response to IL-1 stimulation (6). IRAK-1 associates with 
MyD88 through a homophilic interaction of the death do-
mains (7). Whereas IRAK-1 has a nonredundant role in the 
production of type I IFNs in response to TLR9 ligands in 
plasmacytoid DCs (pDCs; reference 8), IRAK1-defi  cient 
(IRAK-1−/−) macrophages show modest impairment in IL-1R– 
and TLR-mediated proinfl  ammatory cytokine production 
(9, 10). IRAK-2 is suggested to be involved in the signaling 
via TIRAP/Mal, an adaptor protein responsible for TLR2 
and TLR4 responses (11). In contrast, IRAK-M was identi-
fi  ed as the negative regulator of the TLR/IL-1R signaling 
(12). The fourth member of IRAK family members, IRAK-4, 
has been discovered by a database search (13). Generation 
of IRAK-4−/− mice revealed its essential role in IL-1R/TLR–
mediated responses (14, 15). Furthermore, the poor defenses 
against bacterial infection were observed in patients having 
autosomal recessive amorphic mutations in IRAK-4 (16, 17). 
It was suggested that IRAK-4 can directly phosphorylate 
IRAK-1 for the signaling. Recently, IRAK-4 has been re-
ported to be a requisite for TCR-induced NF-κB activation 
by associating with ZAP-70 (18).
Although IRAK family members are involved in TLR/
IL-1R signaling, the role of their kinase activity is still con-
troversial. Among IRAK family members, IRAK-1 and -4 
were shown to possess intrinsic kinase activity (13, 19). Nev-
ertheless, it has been shown that IRAK-1 kinase activity is 
dispensable for its ability to activate NF-κB (20). IRAK-1 
could act as a scaff  old protein recruiting MyD88 and TRAF6 
for the signaling (13). Second, a critical aspartate residue in 
the catalytic domain has changed to an asparagine or a serine 
in IRAK-2 or -M, and their kinase domains have been shown 
to be inactive (21). Regarding the requirement of IRAK-4 
activity for the IL-1R signaling, two controversial observa-
tions have been reported to date (22, 23). One paper showed 
that the reconstitution with the kinase-inactive mutant 
IRAK-4 fully restored IL-1 responsiveness (22), whereas the 
other showed that the same reconstitution was capable of re-
storing only a partial cytokine response to IL-1β (23). There-
fore, the requirement of kinase activity in IRAK family 
members has not been well understood.
In the present study, we generated mice carrying a knockin 
mutation that abrogated IRAK-4 activity. For the assessment 
of the roles of kinase activity, we also generated IRAK-4−/− 
mice. The analysis of these mice revealed that the kinase acti-
vity of IRAK-4 is essential for the physiological function 
of IRAK-4, and the TLR-mediated proinfl  ammatory respon-
ses are severely impaired in these mice. Nevertheless, we did 
not observe any defects in the T cell responses in either 
IRAK-4−/− or IRAK-4KN/KN mice. This study demonstrates 
Figure 1.  Generation of IRAK-4KN/KN mice. (A) Schematic representa-
tion of IRAK-4 (KK213AA) knockin allele. The targeting vector contains 
point mutations in exon 2 that change lysines at position 213 and 214 to 
alanine (KK213AA). (B) Southern blot analysis of offspring from the hetero-
zygote intercrosses. Genomic DNA was extracted from mouse tails, 
digested with BamHI, separated by electrophoresis, and hybridized with 
the radiolabeled probe indicated in A. (C) Nothern blot analysis of the 
expression of IRAK-4 mRNA. Total RNA from wild-type, IRAK-4−/−, and 
IRAK-4KN/KN peritoneal macrophages were extracted and subjected to the 
Northern blot analysis for the expression of IRAK-4 mRNA. The same 
membrane was rehybridized with a β-actin probe. (D) Immunoblot analy-
sis for the expression of IRAK-4 protein expression in wild-type (+/+), 
IRAK-4−/− (−/−), and IRAK-4KN/KN (KN/KN) macrophages. Cell lysates 
from peritoneal macrophages stimulated with 10 ng/ml MALP-2 for the 
indicated times were immunoblotted with Ab to IRAK-4. Probing for 
ERK1/2 was used to ensure equal loading. (E) PCR amplifi  cation products 
from wild-type (+/+) and IRAK-4KN/KN (KN/KN) macrophages were sub-
cloned and sequenced to demonstrate the presence of the KK213AA 
mutation; representative traces are shown. JEM VOL. 204, May 14, 2007  1015
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that IRAK-4 functions as an actual kinase for relaying the 
TLR signaling.
RESULTS
Generation of IRAK-4KN/KN and IRAK-4−/− mice
It has been shown that a mutation in ATP binding pocket 
(K239S) of IRAK-1 abrogated its kinase activity. Neverthe-
less, overexpression of this mutant IRAK-1 still effi   ciently 
induced NF-κB activation. Corresponding mutations in 
IRAK-4 (KK213AA) was capable of inducing activation of 
NF-κB in response to IL-1β stimulation. These results sug-
gested that IRAK family members function as adaptor mole-
cules for the signaling, and the IRAK kinase activity was 
dispensable for their function. To identify the role of IRAK-4 
activity in TLR signaling, we inserted a mutation (KK213AA) 
of IRAK-4. To replace serines 213 and 214 of IRAK-4 with 
alanines, a loxP-fl  anked Neo cassette was inserted. Serine to 
alanine substitutions were introduced by site-directed muta-
genesis (Fig. 1 A). A targeting vector containing these muta-
tions were electroporated into embryonic stem (ES) cells, 
clones with homologous recombination at the IRAK-4 locus 
were obtained, and IRAK-4–mutated mice were generated. 
The mice were crossed with CAG-Cre transgenic mice to 
excise the neo resistant gene. Homologous recombination 
of IRAK-4 locus was confi  rmed by Southern blotting, and 
the sequencing analysis revealed that the mutations were 
correctly introduced (Fig. 1, B and E). The Northern blot 
and immunoblot analysis showed that IRAK-4 messenger 
RNA (mRNA) and protein were expressed in wild-type and 
IRAK-4KN/KN macrophages, although the expression of IRAK-4 
protein was slightly reduced in IRAK-4KN/KN macrophages 
(Fig. 1, C and D).
We also generated IRAK-4−/− mice by homologous re-
combination to compare the importance of kinase activity 
of IRAK-4 (Fig. S1, A and B, available at http://www.jem
.org/cgi/content/full/jem.20061523/DC1). For generation of 
IRAK-4−/− mice, we targeted exon 2 of mouse IRAK-4 gene 
with the neo cassette in ES cells and established IRAK-4−/− 
mice. Absence of IRAK-4 protein in IRAK-4−/− macro-
phages was confi  rmed by Northern blotting and immuno-
blotting (Fig. 1, C and D).
In vitro kinase assay revealed that IRAK-4 autophos-
phorylation was induced in wild-type macrophages in re-
sponse to TLR2 stimulation (Fig. 2 A). In contrast, the 
autophosphorylation of IRAK-4 was not observed either in 
IRAK-4KN/KN or IRAK-4−/− cells. To further investigate 
whether the mutant IRAK-4 can phosphorylate IRAK-1, 
we isolated IRAK-4 cDNA from wild-type and IRAK-4KN/KN 
cells. The IRAK-4 proteins were expressed using the rabbit 
reticulocyte lysate system, and in vitro kinase assay was per-
formed with mouse IRAK-1 protein (aa 301–500), which 
contains an activation loop, as a substrate. As shown in Fig. 
2 B, the wild-type IRAK-4, but not IRAK-4 (KK213AA), 
phosphorylated IRAK-1. Immunoblot analysis revealed that 
the amounts of wild-type and IRAK-4 (KK213AA) expressed 
were not altered (Fig. 2 B).
We next examined whether IRAK-4 activity was re-
quired for the recruitment of IRAK-4 in the complex of 
Figure 2.  The kinase activity in IRAK-4KN/KN mice. (A) Peritoneal 
macrophages were stimulated with 10 ng/ml MALP-2 for 0, 10, and 
20 min. The cell lysates were prepared and immunoprecipitated with anti–
IRAK-4 Ab. The kinase activity of IRAK-4 was measured by in vitro kinase 
assay. The data shown are representative of three independent experiments. 
Auto, autophosphorylation. (B) IRAK-4 cDNA was obtained from total 
RNA of wild-type and IRAK-4KN/KN macrophages. Wild-type and 
KK213AA IRAK-4 proteins were expressed in the rabbit reticulocyte 
lysates, and in vitro kinase assay was performed in the presence of IRAK-1 
(aa 301–500; top panel). The expression of wild-type and KK213AA IRAK-4 
and IRAK-1 (aa 301–500) was determined by immunoblot analysis 
(bottom panel). (C) Interaction of MyD88 and IRAK-4. MEFs were stimulated 
with 10 ng/ml IL-1β for the indicated periods. The cell lysates were 
immunoprecipitaed with anti-MyD88, followed by immunoblot with anti–
IRAK-4 and anti-MyD88. (D) IL-1β–induced coprecipitation of IRAK-1 
and -4. The cell lysates prepared in C were immunoprecipitated with anti–
IRAK-4, followed by immunoblot with anti–IRAK-1 and anti–IRAK-4.1016  IRAK-4-NEGATIVE KNOCKIN MICE | Kawagoe et al.
MyD88 and IRAK-1 in response to IL-1R stimulation. 
When mouse embryonic fi  broblasts (MEFs) were stimulated 
with IL-1β, IRAK-4 was coprecipitaited with MyD88 in 
both wild-type and IRAK-4KN/KN cells (Fig. 2 C). In con-
trast, interaction between IRAK-4 and -1 was not induced in 
IRAK-4KN/KN macrophages (Fig. 2 D). These results indicate 
that IRAK-4 activity is dispensable for the recruitment of 
IRAK-4 to MyD88, although the kinase activity is essential 
for the recruitment of IRAK-1 to -4.
The role of IRAK-4 activity in TLR-induced responses
We fi  rst examined the role of IRAK-4 activity in response to 
TLR ligand stimulation in vivo. After challenge with LPS or 
CpG-DNA together with d-galactosamine, wild-type mice 
succumbed to shock and died, whereas all IRAK-4−/− and 
IRAK-4KN/KN mice survived, indicating that the kinase activ-
ity of IRAK-4 is critical for the TLR-induced shock in vivo 
(Fig. 3, A and B). We examined cytokine production of 
  macrophages possessing mutated IRAK-4 against TLR ligands, 
including macrophage-activating lipopeptide-2 (MALP-2; 
TLR6/TLR2), poly I:C (TLR3), LPS (TLR4), R-848 (TLR7), 
and CpG-DNA (TLR9). Thioglycollate-elicited peritoneal 
macrophages were stimulated with each TLR ligand and the 
production of proinfl  ammatory cytokines was measured by 
ELISA. In accordance with a previous paper, production of 
IL-6, TNF-α, and IL-12p40 in response to these TLR ligands 
except poly I:C was severely impaired in IRAK-4−/− macro-
phages compared with wild-type cells (14). The production 
of IL-6, TNF-α, and IL-12p40 was also profoundly impaired 
in IRAK-4KN/KN cells, and the extent of reduction was similar 
to that of IRAK-4−/− cells (Fig. 3, C–E). In contrast, IL-6 
and TNF-α production in response to poly I:C was not al-
tered between wild-type, IRAK-4−/−, and IRAK-4KN/KN 
macrophages. DCs from IRAK-4KN/KN mice also showed de-
fective cytokine production in response to these TLR ligands 
(unpublished data). Thus, the IRAK-4 activity is important 
for evoking cytokine production in response to various TLR 
ligands, except for TLR3 ligand.
Not only proinfl  ammatory cytokines but also type I IFNs 
are strongly induced in response to TLR7 and TLR9 stimula-
tion in pDCs (8, 17, 24). It has been shown that IRAK-4 and 
-1 are essential for TLR9-induced type I IFN production in 
pDCs. To examine the role of IRAK-4 activity in type I IFN 
response, we generated pDCs by cultivating bone-marrow 
cells in the presence of Flt3 ligand.  Whereas wild-type Flt3L-
DCs produced IFN-α and IL-6 in response to A/D-type 
Figure 3.  Essential role of IRAK-4 activity in TLR-mediated cyto-
kine responses. (A and B) Age-matched wild-type (n = 10), IRAK-4−/− 
(n = 5), and IRAK-4KN/KN (n = 5) mice were challenged with 2 mg LPS 
(A) and 20 nmol CpG-DNA together with 20 mg D-galactosamine (B). The 
survival of mice was monitored for 5 d. (C–E) Thioglycollate-elicited peri-
toneal macrophages from wild-type, IRAK-4−/−, and IRAK-4KN/KN mice 
were stimulated with MALP-2, poly I:C, LPS, R-848, and CpG-DNA for 
24 h. For measuring IL-12 p40 concentration, macrophages were stimu-
lated with the indicated TLR ligands in the presence of 30 ng/ml IFN-γ. 
Concentrations of IL-6 (C), TNF-α (D), and IL-12 p40 (E) in the culture 
supernatants were measured by ELISA. Data are shown as mean ± SD of 
triplicates. Similar results were obtained in three independent experiments. 
(F and G) Flt3L-DCs from wild-type, IRAK-4−/−, and IRAK-4KN/KN mice 
were stimulated with the indicated concentrations of A/D type CpG-DNA. 
Production of IFN-α (D) and IL-6 (E) was measured by ELISA. Data are 
representative of three independent experiments. Indicated values are 
mean ± SD of triplicates.JEM VOL. 204, May 14, 2007  1017
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CpG-DNA, cells from neither IRAK-4−/− nor IRAK-4KN/KN 
mice produced both IFN-α and IL-6 (Fig. 3, F and G).
Next we investigated the proliferation of B cells in re-
sponse to these TLR ligands. When we stimulated purifi  ed 
B cells with MALP-2, poly I:C, LPS, R-848, and CpG-DNA, 
wild-type B cells proliferated in a dose-dependent manner 
(Fig. 4). In contrast, IRAK-4−/− as well as IRAK-4KN/KN 
B cells failed to proliferate in response to MALP-2, LPS, 
R-848, and CpG-DNA. Stimulation with poly I:C induced 
proliferation of B cells even in IRAK-4−/− and IRAK-4KN/KN 
mice, suggesting that TLR3 signals independent of IRAK-4 
in B cells. The proliferative responses against anti-IgM, anti-
CD40 antibodies (Abs) were not altered in wild-type, IRAK-
4−/−, and IRAK-4KN/KN splenocytes, indicating that the 
MyD88-dependent responses were specifi  cally impaired in 
IRAK-4−/− or IRAK-4KN/KN cells. Collectively, the kinase 
activity of IRAK-4 is essential for the pleiotrophic eff  ects in 
response to TLR stimulation.
Expression of TLR-mediated gene expression in IRAK-4 
mutated mice
We examined whether the defects in cytokine response to 
TLR stimulation in IRAK-4 mutation were regulated in a 
gene expression level by Northern blot analysis. We chose 
TLR2 ligands as the stimulant because TLR2 signals only via 
the MyD88-dependent pathway. In response to MALP-2 stim-
ulation, wild-type macrophages induced expression of IL-6, 
TNF-α, IκBζ, and cyclooxygenase-2 (COX-2) genes (Fig. 5 A). 
In contrast, IRAK-4−/− and IRAK-4KN/KN macrophages failed 
to express IL-6 and COX-2 in response to MALP-2 stimu-
lation. However, TNF-α and IκBζ were expressed even in the 
absence of IRAK-4, albeit the expression was weaker than 
wild-type cells. Thus, the kinase activity of IRAK-4 is criti-
cal for regulating IRAK-4–mediated controlling of gene 
expression. Indeed, TNF bioassay revealed that a subtle amount 
of TNF activity was induced 1 and 2 h after MALP-2 stimu-
lation in IRAK-4−/− and IRAK-4KN/KN macrophages, al-
though the amount was much smaller than in wild-type cells 
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20061523/DC1). Interestingly, MyD88−/− macrophages 
failed to induce any detectable amount of these genes in response 
to MALP-2 stimulation (Fig. 5 A). In addition, PAM3CSK4, 
a synthetic lipopeptide known to be recognized by TLR1/
TLR2 heterodimer, also induces expression of TNF-α and 
IκBζ even in the absence of IRAK-4 (Fig. 5 B; reference 25). 
These results indicate that the early expression of TNF-α and 
IκBζ genes in response to TLR2 ligands is regulated in part in 
a IRAK-4–independent fashion, although IRAK-4 plays a 
major role in the expression of TLR2-inducible genes.
Figure 4.  IRAK-4 activity is critical for TLR-mediated proliferation 
of splenocytes. Splenocytes were cultured with the indicated concentra-
tions of MALP-2, poly I:C, LPS, R-848, CpG-DNA, anti-IgM, or anti-CD40 
for 48 h. Samples were pulsed with 1 μCi [3H]thymidine for the last 16 h. 
[3H]thymidine incorporation was measured by a scintillation counter. Data 
are representative of three independent experiments. Indicated values are 
mean ± SD of triplicates.
Figure 5.  IRAK-4–independent induction of gene expression in 
TLR signaling. (A and B) Peritoneal macrophages were stimulated with 
10 ng/ml MALP-2 (A) and 10 ng/ml PAM3CSK4 (B) for the indicated peri-
ods. Total RNA was extracted and subjected to Northern blot analysis for 
expression of IL-6, TNF-α, Iκ Bζ, and COX-2. The same membrane was 
rehybridized with a β-actin probe.1018  IRAK-4-NEGATIVE KNOCKIN MICE | Kawagoe et al.
The role of IRAK-4 activity in the TLR-mediated 
signaling pathway
These observations prompted us to examine intracellular sig-
naling pathways in response to TLR stimulation. It has been 
shown that IRAK-4 is recruited to IL-1R in response to 
  ligand stimulation, where it phosphorylates and activates 
IRAK-1. It was also shown that IRAK-4 is essential for the 
initiation of IL-1R–mediated signaling pathways leading to 
the activation of NF-κB and MAP kinases in MEFs (14).
TLR2-mediated autophosphorylation of IRAK-1 was 
completely abrogated in IRAK-4−/− and IRAK-4KN/KN macro-
phages (Fig. 6 A). TLR/IL-1R stimulation induces not only 
phosphorylation but also degradation of IRAK-1. MALP-2 
stimulation decreased the IRAK-1 expression in wild-type 
macrophages (Fig. 6 B). However, TLR2-mediated degradation 
of IRAK-1 was not observed in IRAK-4−/− and IRAK-4KN/KN 
macrophages. Thus, IRAK-4 activity is essential for IRAK-1 
activation in response to TLR2 activation.
We examined the role of IRAK-4 activity in the activa-
tion of MAP kinases and NF-κB in macrophages. First, acti-
vation of c-Jun N-terminal kinase (JNK), p38, and extracellular 
signal-regulated kinase (ERK) induced by MALP-2 was pro-
foundly impaired in IRAK-4−/− as well as IRAK-4KN/KN 
macrophages (Fig. 6, C–E). These results indicate that IRAK-4 
activity is critical for the activation of MAP kinases in the 
TLR signaling.
We analyzed activation of NF-κB. Phosphorylation and 
degradation of IκBα were also severely impaired in IRAK-
4−/− and IRAK-4KN/KN macrophages (Fig. 7, A and B). 
MALP-2–induced phosphorylation of NF-κB p65 was not 
observed in IRAK-4−/− and IRAK-4KN/KN macrophages 
(Fig. 7 C). Nevertheless, an electrophoretic mobility shift as-
say (EMSA) revealed that the NF-κB–DNA binding activity 
was clearly induced even in the absence of IRAK-4, although 
the activation was  10 min delayed compared with wild-
type cells (Fig. 7 D). Consistent with our previous study, 
MyD88−/− macrophages failed to induce NF-κB–DNA 
binding activity in response to MALP-2 (Fig. S3, available at 
http://www.jem.org/cgi/content/full/jem.20061523/DC1; 
reference 26). These results indicate that TLR2 activates 
a MyD88-dependent and IRAK-4–independent signaling 
pathway leading to the activation of NF-κB. To assess the 
subunits of the NF-κB complexes observed in response to 
MALP-2 stimulation, we performed supershift assays using 
anti-p65 or anti-p50 Ab and nuclear extracts from macro-
phages stimulated with MALP-2 for 40 min (Fig. 7 E). In 
wild-type and IRAK-4–mutated cells, the bands were super-
shifted with anti-p65 and anti-p50 Ab, suggesting that the 
NF-κB complex is mainly composed of p65/p50 hetero-
dimers in both wild-type and IRAK-4–mutated cells. These 
fi  ndings indicate that TLR2 activates a MyD88-dependent 
and IRAK-4–independent signaling pathway leading to the 
Figure 6.  IRAK-4 is critical for TLR-mediated activation of IRAK-1 
and MAP kinases. (A) In vitro kinase assay for IRAK-1 activation. Perito-
neal macrophages were stimulated with 10 ng/ml MALP-2 for the indi-
cated periods. The cell lysates were prepared and immunoprecipitated 
with anti-IRAK-1 Ab, and the kinase activity of IRAK-1 was measured by 
in vitro kinase assay. The data shown are representative of three indepen-
dent experiments. Auto, autophosphorylation. (B) Immunoblot analysis for 
the change in IRAK-1 expression in response to MALP-2 stimulation. Peri-
toneal macrophages from wild-type, IRAK-4−/−, and IRAK-4KN/KN mice 
were stimulated with MALP-2 for the indicated periods. Whole cell lysates 
were subject to immunoblot analysis using anti–IRAK-1. ERK1/2 levels are 
shown as loading control. (C–E) Macrophages from wild-type, IRAK-4−/−, 
and IRAK-4KN/KN mice were stimulated with MALP-2 for the indicated 
periods, and whole cell lysates were subject to immunoblot analysis using 
anti–phospho-JNK (C), anti–phospho-P38 (D), and anti–phospho-ERK (E). 
The blots of JNK, p38, and ERK are shown as loading controls. Similar 
results were obtained in three independent experiments.JEM VOL. 204, May 14, 2007  1019
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activation of NF-κB. Stimulation with R-848 and CpG-
DNA also induced NF-κB activation in an IRAK-4–inde-
pendent manner without degrading IκBα (Fig. S4). When 
IRAK-4–mutated cells were stimulated with LPS, degrada-
tion of IκBα as well as NF-κB–DNA binding was delayed as 
observed in MyD88−/− macrophages (Fig. S4). These data 
indicate that the IRAK- 4–independent pathway is activated 
downstream of various TLRs.
Activation of NF-κB in the IRAK-1–independent and IRAK-4–
dependent signaling pathway
It was revealed that the death domain of MyD88 is responsi-
ble for triggering downstream signaling cascades. Given that 
only IRAK-4 and -1 have intrinsic kinase activity, it was hy-
pothesized that IRAK-4 and -1 function redundantly in acti-
vating NF-κB. Therefore, we generated IRAK-1/IRAK-4 
doubly defi  cient mice and examined the response to MALP-2. 
As shown in Fig. 7 F, the activation of NF-κB–DNA binding 
activity was induced even in the absence of both IRAK-1 
and -4. Furthermore, TLR2-induced TNF-α gene induction 
was still observed in IRAK-1−/−IRAK-4−/− macrophages 
(unpublished data). Thus, IRAK-1– and IRAK-4–independent 
mechanisms are responsible for the signaling pathway leading 
to the activation of NF-κB.
Normal TCR responses in IRAK-4−/− and IRAK-4KN/KN T cells
A recent study has shown that defi  ciency in IRAK- 4 results 
in the impaired responses to TCR stimulation (18). IRAK-4 
interacts with ZAP-70 in the cells and regulates TCR-
mediated activation of NF-κB. We then analyzed responses 
of IRAK-4KN/KN mice to TCR stimulation. Surprisingly, 
proliferation of purifi  ed T cells in response to either immobi-
lized or soluble anti-CD3 was not impaired in either IRAK-
4−/− or IRAK-4KN/KN mice compared with wild-type mice 
Figure 7.  IRAK-4–independent activation of NF-κB in TLR2 
sign  aling. (A–C) Macrophages from wild-type, IRAK-4−/−, and IRAK-4KN/KN 
mice were stimulated with MALP-2 for the indicated periods. Whole cell 
lysates were subject to immunoblot analysis using anti-IκBα (A), anti–
phospho-IκBα (B), and anti–phospho-NF-κB p65 Abs (C). The blots of 
ERK1/2 and NF-κB p65 are shown as loading controls. The data are repre-
sentative of three independent experiments. (D) Wild-type, IRAK-4−/−, 
and IRAK-4KN/KN macrophages were stimulated with 10 ng/ml MALP-2 for 
the indicated periods. Nuclear extracts were then prepared, and NF-κB–
DNA binding activity was determined by EMSA using an NF-κB–specifi  c 
probe. (E) Nuclear extracts from macrophages stimulated with MALP-2 for 
40 min were incubated with Abs specifi  c to NF-κB p65 and p50 before 
addition of NF-κB probe. The single and double asterisks indicate the 
supershifts induced by Ab to p65 and p50, respectively. (F) IRAK-1/IRAK-4–
independent activation of NF-κB in response to TLR stimulation. Wild-
type, IRAK-4−/−, IRAK-1−/−, and IRAK-4−/−IRAK-1−/− doubly defi  cient 
macrophages were stimulated with 10 ng/ml MALP-2 for the indicated 
periods. NF-κB–DNA binding activity was determined by EMSA.1020  IRAK-4-NEGATIVE KNOCKIN MICE | Kawagoe et al.
(Fig. 8 A and Fig. S5, available at http://www.jem.org/cgi/
content/full/jem.20061523/DC1). In addition, production 
of IL-2 in response to TCR stimulation was not impaired in 
T cells from these mice (Fig. 8 B). Furthermore, wild-type, 
IRAK-4−/−, and IRAK-4KN/KN T cells have equivalent 
  ability to proliferate in response to allogenic DCs either 
untreated or treated with various TLR ligands, including 
MALP-2, LPS, and CpG-DNA (Fig. 8 C). Moreover, 
TCR-mediated activation of NF-κB as well as MAP kinases 
was also not altered between wild-type, IRAK-4−/−, and 
IRAK-4KN/KN T cells (Fig. 8, D and E). We investigated 
whether IRAK-4 was involved in adaptive T cell responses 
in vivo. Wild-type and IRAK-4−/− mice were infected with 
lymphocytic choriomeningitis virus (LCMV). Splenocytes 
were prepared 8 d after infection, and induction of LCMV-
specifi  c CD8+ T cells was analyzed by tetramer staining. As 
shown in Fig. 9 A, LCMV-specifi  c CD8+ T cells were in-
duced both in wild-type and IRAK-4−/− mice in a similar 
manner after infection. Similarly, wild-type and IRAK-4−/− 
mice induced comparable ex vivo CTL responses as deter-
mined in a 51Cr release assay (Fig. 9 B). These results indi-
cate that IRAK-4 is not involved in the TCR signaling 
leading to the activation of NF-κB as well as T cell responses 
in vivo.
D  I  S  C  U  S  S  I  O  N 
In the present study, we analyzed the role of IRAK-4 activity 
in vivo by generating mice with knockin mutation KK213AA 
and with null mutation. In agreement with previous papers, 
IRAK-4−/− macrophages showed severe defects in TLR-
mediated cytokine responses (14, 15). Although the expres-
sion of IRAK-4 protein was slightly lower than wild-type 
cells, IRAK-4KN/KN macrophages also showed profound de-
fects in the responses to various TLR ligands to the same ex-
tent as IRAK-4−/− cells. These results clearly indicate that the 
kinase activity of IRAK-4 is essential for the function of 
IRAK-4 in vivo. Previous in vitro studies implicated that the 
IRAK family members could activate NF-κB and infl  am-
matory responses even in the absence of their kinase activity 
(19, 20). In the case of IRAK-4, one group has shown that the 
mutant IRAK-4 (KK213AA) restored IL-1β responsiveness 
(22), and the other group reported that the same mutation 
could restore the response only partially (23). It has been 
shown that expression of kinase-inactive IRAK-1 could also 
restore IL-1β–induced NF-κB activation. It may be possible 
that overexpressed IRAK-4 behaved diff  erently compared 
with the physiological expression. In the physiological level 
of expression, the kinase activity of IRAK-4 is critical for its 
function. So far IRAK-4 substrates responsible for the signaling 
Figure 8.  IRAK-4 is dispensable for TCR signaling. (A) Splenic T cells 
from wild-type, IRAK-4−/−, and IRAK-4KN/KN mice were stimulated with 
immobilized (plate-bound) anti-CD3 (5 μg/ml) alone or anti-CD3 (5 μg/ml) 
plus anti-CD28 (2 μg/ml) for 48 h. The cells were pulsed with 1 μCi 
[3H]thymidine for the last 16 h. [3H]thymidine incorporation was mea-
sured by a β-scintillation counter. (B) Splenic T cells were stimulated with 
5 μg/ml anti-CD3 plus 2 μg/ml anti-CD28 for 72 h. IL-2 concentrations in 
the culture supernatant were measured by ELISA. (C) Allogenic activity of 
wild-type, IRAK-4−/−, and IRAK-4KN/KN T cells. T cells from indicated mice 
were mixed with bone-marrow DCs from BALB/c mice stimulated with 
MALP-2, LPS, and CpG-DNA. (D) Normal activation of NF-κB in response 
to TCR in IRAK-4−/− and IRAK-4KN/KN mice. The cell lysates from cells stim-
ulated with plate-bound anti-CD3 plus anti-CD28 were immunoblotted 
with anti-IκBα. ERK1/2 levels are shown as loading control. (E) Normal 
activation of ERK in IRAK-4−/− and IRAK-4KN/KN mice. Wild-type, IRAK-4−/−, 
and IRAK-4KN/KN T cells were stimulated with plate-bound anti-CD3 plus 
anti-CD28, and the cell lysates were immunoblotted with anti–phospho-
ERK. ERK1/2 levels are shown as loading control.JEM VOL. 204, May 14, 2007  1021
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have not been well understood. Although it was shown that 
IRAK-4 phosphorylated IRAK-1 for activating TRAF6, 
TLR-mediated production of proinfl  ammatory cytokines in 
IRAK-1−/− cells was not impaired in peritoneal macrophages. 
Further studies are required for identifying substrates other 
than IRAK-1 that are responsible for the TLR signaling 
pathway. Nevertheless, this is the fi  rst paper showing that the 
kinase activity of IRAK family members plays a critical role 
in their function in vivo.
The association between MyD88 and IRAK-4 was in-
duced in response to IL-1β stimulation in both wild-type and 
IRAK-4KN/KN cells. A previous study showed that MyD88 
interacted with kinase-negative, but not with wild-type, 
IRAK-4 when they were overexpressed in human embry-
onic kidney 293 cells (13). In contrast, it was reported that 
IL-1 stimulation induced an interaction between endogenous 
MyD88 and wild-type IRAK-4 (16). In that study, the ki-
nase-truncated mutant of IRAK-4 was shown to constitu-
tively interact with MyD88 even before IL-1 stimulation. 
Given that overexpression of wild-type IRAK-4 immedi-
ately activates NF-κB without further stimulation, the local-
ization of overexpressed IRAK-4 may be diff  erent  from 
endogenous protein. Based on our observation and that study 
(16), the endogenous IRAK-4 is probably recruited to 
MyD88 in response to stimulation, and IRAK-4 with 
KK213AA point mutation behaves similarly to wild-type 
IRAK-4 regarding association with MyD88.
Although IRAK-4 defi  ciency profoundly aff  ected TLR2-
mediated cytokine production, TNF-α gene induction was 
impaired, but not abrogated, as observed in MyD88 defi  -
ciency. TLR2-mediated expression of TNF-α and IκBζ genes 
was induced even in the absence of IRAK-4, though the ex-
pression in IRAK-4−/− and IRAK-4KN/KN cells was reduced 
and transient compared with wild-type cells. Furthermore, 
induction of NF-κB–DNA binding activity was also induced 
in IRAK-4−/− and IRAK-4KN/KN macrophages, although the 
activation was  10 min delayed compared with wild-type 
cells. This fi  nding is in contrast to the complete abrogation 
of TLR2 signaling in MyD88−/− macrophages and indicates 
the existence of an IRAK-4–independent signaling pathway. 
Stimulation with R-848 and CpG-DNA also induced NF-κB 
activation in an IRAK-4–independent manner without de-
grading IκBα, suggesting that the IRAK-4–independent 
pathway is not TLR2 specifi  c. Given that the death domain 
of MyD88 is responsible for downstream signaling, other 
IRAK family members that contain an N-terminal death 
domain are candidates for mediating IRAK-4–independent 
signaling. Nevertheless, the activation of NF-κB in response 
to a TLR2 ligand was observed even in the absence of both 
IRAK-1 and -4. Because it was shown that IRAK-2 also 
positively regulated the IL-1β–signaling pathway, IRAK-2 
may be responsible for the signaling pathway. Future studies 
will clarify if IRAK family members redundantly function in 
IL-1R/TLR responses in vivo. Although we clearly detected 
NF-κB–DNA binding activity, which is supershifted by anti-
p50 and p65 Ab, we failed to detect activation of IKKs and 
phosphorylation of IκBα in the absence of IRAK-4 or its 
kinase activity in response to TLR2 stimulation. Induction 
of NF-κB activation without degradation of IκBα is quite 
unique, although the mechanism of activation is enigmatic. It 
has been reported that TLR2 stimulation leads to the recruit-
ment of active Rac1 and phosphatidylinositol-3 kinase to the 
TLR2 cytosolic domain (27). Therefore, it is possible that the 
signaling is mediated through the small G protein–phosphati-
dylinositol-3 kinase pathway.
The TLR/IL-1R and antigen-receptor signaling share 
signaling molecules for activating NF-κB. In addition to 
IKK complex, TRAF6 was also reported to be involved in 
TCR-mediated NF-κB activation (28). TRAF6 can associ-
ate with MALT1, which forms a complex with BCL10 and 
CARMA1/CARD11. TRAF6 is oligomerized by the com-
plex and activates IKKs by inducing polyubiquitination of 
IKK-γ/NF-κB essential modulator and activation of TGF-
β–activated kinase 1. A recent paper showed that IRAK-4 
was also involved in TCR responses via suppressing NF-κB 
activation by associating with ZAP-70 (18). However, the 
newly generated IRAK-4−/− mice did not show any defects 
in the T cell response as well as the TCR signaling pathway. 
Furthermore, IRAK-4 was not required for LCMV-induced 
CTL responses. IRAK-4KN/KN T cells also showed normal 
responses against TCR stimulation. We do not have a clear 
explanation for the discrepancy, and it may be due to the dif-
ference in the genetic background of the strains. However, it 
is unlikely that the critical TCR signaling components are 
diff  erent between mouse strains, suggesting that IRAK-4 is 
not critically involved in TCR signaling.
In summary, this study demonstrates that IRAK-4 activity 
plays a critical role in the physiological function of IRAK-4. 
Macrophages and DCs from IRAK-4KN/KN mice as well as 
IRAK-4−/− mice were profoundly defective in TLR-mediated 
Figure 9.  Responses of IRAK-4−/− T cells to LCMV infection. Wild-
type and IRAK-4−/− mice were intravenously infected with 5 × 105 PFU 
of LCMV, and splenocytes were harvested at day 8 after infection. (A) The 
cells were stained with LCMV MHC class I tetramer and CD8a and were 
analyzed by fl  ow cytometry. The data shown are representative of six 
different mice tested. (B) Ex vivo CTL activity in splenocytes was deter-
mined using 5-h 51Cr release assay and GP33-loaded EL-4 cells as targets. 
Indicated values are mean ± SD of three mice. The data are representa-
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proinfl  ammatory cytokine production. In addition, IRAK-4KN/KN 
mice were highly resistant to LPS-induced shock response. 
The exploration of small compounds targeting kinase activity 
of IRAKs has been challenged by the fact that expression 
of even kinase-inactive IRAK-4 mutant results in the activa-
tion of the intracellular signaling pathway. However, this 
study clearly indicates that the kinase activity of IRAK-4 
is essential for the physiological functions, and the kinase 
activity of IRAK-4 is a good therapeutic target for infl  amma-
tory diseases and septic shock, without aff  ecting acquired 
immune responses.
MATERIALS AND METHODS
Generation of IRAK-4KN/KN mice. The IRAK-4 gene was isolated from 
genomic DNA extracted from ES cells (GSI) by PCR. A genomic fragment 
containing exon 2 of IRAK-4 was cloned into a pT7blue vector (Nugen), 
and point mutations resulting in the KK213AA conversion in the kinase do-
main were introduced by a site-directed mutagenesis. A targeting vector has 
a neomycin-resistance gene cassette (neo) fl  anked with two loxP sites, and a 
HSV thymidine kinase driven by PGK promoter was inserted into the ge-
nomic fragment for negative selection. The targeting vector was linearized 
and electroporated into ES cells (GSI). G418 and gancyclovir doubly resis-
tant clones were selected and screened by PCR and further confi  rmed by 
Southern blotting. Three clones with homologous recombination were in-
jected into blastocysts from C57BL/6 females, the obtained chimeric males 
were crossed with C57BL/6 females, and the obtained F1 generations with 
mutated IRAK-4 mice were crossed with CAG-Cre transgenic mice to ex-
cise the neo cassette. CAG-Cre transgene was removed from IRAK-4KN/+ 
mice without a neo cassette by crossing the mice with C57BL/6 mice. 
IRAK-4KN/+ mice were further intercrossed to obtain IRAK-4KN/KN mice. 
The IRAK-4KN/KN mice used were under 129Sv × C57BL/6 background. 
Mice were maintained in our animal facility and treated in accordance with 
the guidelines of Osaka University.
Generation of IRAK-4−/− mice. The IRAK-4 gene was isolated from 
genomic DNA extracted from ES cells (GSI) by PCR. The targeting vector 
was constructed by replacing a 4.3-kb fragment encoding the IRAK-4 ORF 
with a neo cassette, and a HSV thymidine kinase driven by PGK promoter 
was inserted into the genomic fragment for negative selection. After the tar-
geting vector was transfected into ES cells, G418 and gancyclovir doubly re-
sistant colonies were selected and screened by PCR and further confi  rmed 
by Southern blotting. Homologous recombinants were microinjected into 
blastocysts from C57BL/6 female mice, and heterozygous F1 progenies were 
intercrossed to obtain IRAK-4−/− mice. The IRAK-4−/− mice used were 
under 129Sv × C57BL/6 background.
Cells. Peritoneal exudate cells were isolated from the peritoneal cavity of 
mice 3 d after injection with 2 ml of 4.0% thioglycollate medium (Sigma-
Aldrich) by washing with ice cold Hanks’ balanced salt solution (Invitrogen). 
Bone-marrow DCs were prepared by cultivating either in the presence of 
100 ng/ml human Flt3 ligand (PeproTech) or 10 ng/ml mouse GM-CSF 
(PeproTech) as described previously (29). Splenic T cells were isolated using 
MACS (Miltenyi Biotec).
Reagents. MALP-2 and PAM3CSK4 were synthesized as described previ-
ously (25, 26). LPS from Salmonella minesota Re-595 was purchased from 
Sigma-Aldrich. Poly I:C was purchased from GE Healthcare. R-848 was 
  provided by the Pharmaceuticals and Biotechnology Laboratory of the Japan 
Energy Corporation. CpG oligonucleotide was synthesized as described 
previously (30). Polyclonal Ab to phosphorylated JNK (anti– phospho-JNK), 
anti–phospho-p38, anti–phospho-ERK, anti–phospho- IκBα (Ser32), and 
anti–phospho-NF-κB p65 (Ser536) were purchased from Cell Signaling. Poly-
clonal anti-JNK, anti-p38, anti-ERK, and anti–IκB-α were obtained from 
Santa Cruz Biotechnology, Inc. Abs to NF-κB p50 and p65 were purchased 
from Santa Cruz Biotechnology, Inc. Anti-MyD88 Ab was purchased from 
ProSci, and anti–IRAK-1 Ab was made as described previously (25). Rabbit 
anti–IRAK-4 polyclonal Ab was raised against a peptide corresponding to 
aa 436 to 459 of mouse IRAK-4. Specifi  city of this Ab was tested on over-
expressed IRAK-4 (unpublished data) and on IRAK-4−/− cells (Fig. 1 D).
Measurement of cytokine production. Concentrations of cytokines in 
the culture supernatants were measured by ELISA. ELISA kits for mouse 
TNF-α, IL-6, IL-12 p40, and IL-2 were purchased from R&D Systems, and 
the kit for mouse IFN-α was purchased from PBL Biomedical Laboratories.
[3H]thymidine uptake. Splenocytes were cultured with the indicated 
concentrations of MALP-2, poly I:C, LPS, CpG-DNA, anti-IgM (Jackson 
ImmunoResearch Laboratories), or anti-CD40 (BD Biosciences) for 48 h. For 
examining T cell responses, splenic T cells were activated with 10 μg/ml of 
plate-bound anti-CD3 (BD Biosciences) and 2 μg/ml of plate-bound anti-
CD28 (BD Biosciences) for 48 h. Cells were pulsed with 1 μCi [3H]thymidine 
for the last 16 h. [3H]thymidine incorporation was measured by a scintilla-
tion counter (Packard Instrument Co.).
Synthesis of IRAK proteins and in vitro kinase assay. IRAK-4 cDNA 
was obtained by RT-PCR from mRNAs prepared from wild-type and 
IRAK-4KN/KN macrophages. The cDNAs were cloned into a pcDNA3 vec-
tor, which contains a T7 promoter and a Myc tag sequence. Recombinant 
Myc-tagged IRAK-4 proteins were expressed in the rabbit reticulocyte 
lysates using TNT T7 Quick coupled transcription/translation systems 
(Promega). A part of mouse IRAK-1 protein (aa 301–500), which contains 
the IRAK-1 activation loop, was also prepared the by same system. 10 μl of 
reticulocyte lysates, which contained recombinant kinase or exogenous sub-
strate, was diluted with cell lysis buff  er and combined as indicated. Kinase 
and substrate were immunoprecipitated with anti-Myc Ab (Cell Signaling), 
and then in vitro kinase assay was performed as described previously (31). 
For assessing autophosphorylation of endogenous IRAK proteins, peritoneal 
macrophages stimulated with 10 ng/ml MALP-2 were lysed and immuno-
precipitated with anti–IRAK-1 and anti–IRAK-4 Ab. The kinase activity 
was then measured by in vitro kinase assay.
Northern blot analysis. Peritoneal macrophages were treated with 10 ng/ml 
MALP-2 for 0, 1, 2, 4, and 8 h, and total RNA was extracted using TRIzol 
reagent (Invitrogen). RNA was electrophoresed, transferred to nylon mem-
branes, and hybridized with the indicated cDNA probes. To detect the 
  expression of IRAK4 mRNA, a 394-bp fragment (707–1,101) was used as a 
probe. The same membrane was rehybridized with a β-actin probe.
Western blot analysis. Peritoneal macrophages were treated with 10 ng/ml 
MALP-2 for the indicated times. Cells were then lysed in a lysis buff  er 
containing 1.0% NP-40, 150 mM NaCl, 20 mM Tris-Cl, pH 7.5, 1 mM 
EDTA, and protease inhibitor cocktail (Roche). Cell lysates were dissolved 
by SDS-PAGE and transferred onto a polyvinylidene difl  uoride membrane. 
The membrane was blotted with the specifi  c Ab to indicated proteins and 
visualized with an enhanced chemiluminescence system (NEN Life Science 
Products). For immunoprecipitation, 107 MEFs were treated with 10 ng/ml 
IL-1β for the indicated periods, and cell lysates were immunoprecipitated 
with anti-MyD88 or anti–IRAK-4 Ab, followed by immunoblot with the 
indicated Abs.
EMSA. The nuclear extracts were prepared from peritoneal macrophages 
(5 × 106) stimulated with MALP-2 as described previously (4). Nuclear 
extracts were incubated with or without Abs against NF-κB p65 or p50, and 
then further incubated with a specifi  c probe for NF-κB DNA binding sites, 
electrophoresed, and visualized by autoradiography.
Allogenic T cell response assay. The allogenic T cell responses were ana-
lyzed as described previously (32). In brief, bone marrow–derived DCs 
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for 48 h from BALB/c mice were harvested at day 8, irradiated at a dose of 
30 Gy, and plated at threefold serial dilutions in 96-well round-bottom 
plates. These DCs were incubated for 3 d with 5 × 104/well of splenic 
CD4+ T cells from wild-type, IRAK4−/−, and IRAK-4KN/KN mice isolated 
using MACS with CD4 microbeads (Miltenyi Biotec). [3H]thymidine was 
added for the last 16 h. [3H]thymidine incorporation was measured by a 
scintillation counter.
LCMV infection and analysis of T cell responses. LCMV-WE strain 
was obtained from T. Otheki (Akita University, Akita, Japan). Wild-type and 
IRAK4−/− mice were intravenously infected with 5 × 105 PFU of LCMV-
WE and splenocytes were harvested at day 8 after infection. To investigate 
the induction of LCMV-specifi  c T lymphocytes, splenocytes were incubated 
with T-select H-2Db LCMV tetramer-KAVYNFATC-PE (MBL Inter-
national Corporation) and CD8a-APC Ab. Samples were acquired on a FACS 
Calibur (BD Biosciences) and analyzed with FlowJo software (TreeStar).
For assessment of cytotoxicity of LCMV-specifi  c T cells, splenocytes 
prepared from LCMV-infected mice were incubated for 5 h with EL-4 tar-
get cells that had been loaded with a peptide (GP33; KAVYNFATM; Pep-
tide Institute) and labeled with 51Cr. The percentage of specifi  c lysis was 
calculated as [(experimental release − spontaneous release)/(maximal release − 
spontaneous release)] × 100%.
TNF bioassay. TNF activity was measured in macrophage culture super-
natant after stimulation with MALP-2 for 1 and 2 h by cytotoxicity on L929 
fi  broblasts. L929 cells were plated on 96-well plates in RPMI 1640 medium 
supplemented with 2% FCS. Serial twofold dilutions of supernatants in 
8 mg/ml actinomycin D were added to each well and incubated for 20 h. 
Viability of cells was determined using CellTiter-Glo (Promega) according 
to the manufacturer’s instructions. Mouse recombinant TNF-α (R&D systems) 
was used to derive a standard curve, and the concentration of TNF-α was 
determined based on the standard curve.
Online supplemental material. Fig. S1 shows the generation of IRAK-
4−/− mice. Fig. S2 shows the induction of TNF activity in response to 
MALP-2 stimulation. Fig. S3 shows that activation of NF-κB in response 
to MALP-2 was dependent on MyD88. Fig. S4 shows the activation of 
NF-κB in IRAK-4−/− and IRAK-4KN/KN macrophages in response to LPS, 
R-848, and CpG-DNA. Fig. S5 shows the proliferative responses of IRAK-
4−/− and IRAK-4KN/KN T cells to soluble anti-CD3 plus anti-Ig Ab. Online 
supplemental material is available at http://www.jem.org/cgi/content/full/
jem.20061523/DC1.
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